Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evidence Map Analysis on Randomized Controlled Trials: Chinese Patent Medicines and Classic Traditional Chinese Medicine Prescriptions.

Journal of evidence-based medicine·2026
Same author

microRNA-204 as a crucial cancer stem cell related miRNA inhibits stemness of gastric cancer by targeting CD44 and EPCAM.

Journal of translational medicine·2026
Same author

HDL-mimetic peptide treatment reverses APOE4-induced transcriptomic and lipidomic alterations in the brain of humanized APOE mice.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Immunotherapy Resistance in Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.

Cancer letters·2026
Same author

Mechanisms of heavy metal immobilization and transformation during co-pyrolysis of pig manure with typical organic solid wastes.

Journal of hazardous materials·2026
Same author

Repurposing ivacaftor to attenuate LPS-induced acute lung injury: evidence from a non-cystic fibrosis model.

Frontiers in pharmacology·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Danni Li1, Binchong An2, Dereck L Salisbury1

  • 1University of Minnesota, Minneapolis, MN, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

非药物干预措施在轻度认知障碍 (MCI) 患者中没有显著改变阿尔茨海默病的血液生物标志物. 然而,血p-Tau 217和血清自由BDNF显示有可能在六个月内检测对照组的变化.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物研究 生物标志物研究
  • 老年学是一门学科.

背景情况:

  • 血液生物标志物作为阿尔茨海默病 (AD) 非药物干预的替代终点的实用性仍然不确定.
  • 该ACT试验调查了轻度认知障碍 (MCI) 的老年人的神经病理,神经营养和神经炎症生物标志物.

研究的目的:

  • 为了确定ACT试验干预措施 (ACT,骑自行车,SOP) 与对照组相比,在6个月内是否显著改变了血液生物标志物.
  • 评估这些干预措施对血液生物标志物的效果大小.

主要方法:

  • 344名参与者的血液样本在五个时间点 (基线至18个月) 进行了分析.
  • 测量了神经病理 (Ab42,Ab40,NfL,p-Tau 217),神经营养 (IGF-1,IGFBP-3,自由BDNF) 和神经炎症 (GFAP,clusterin) 的生物标志物.
  • 混合效应模型和科恩的d效应大小被用于评估干预效应和群体内部变化.

主要成果:

  • 干预组和对照组在3个月或6个月后之间没有观察到生物标志物水平的显著差异.
  • 大多数生物标志物显示小组内效应大小 (科恩d<0.2).
  • 血p-Tau 217 (d=0.27) 和血清自由BDNF (d=0.71) 在对照组中在6个月后表现出小到中等的效果大小.

结论:

  • 在ACT试验中,非药物干预没有对血液中阿尔茨海默病生物标志物产生显著变化.
  • 血p-Tau 217和血清自由BDNF显示出在6个月内检测MCI老年人的变化潜力,特别是在对照组中.